Methionine sulfoxide reductase A knockout (MsrA −/− ) mice, which serve as a potential model for neurodegeneration, suffer from increased oxidative stress and have previously been found to have chronically elevated brain dopamine content levels relative to control mice. Additionally, these high levels parallel increased presynaptic dopamine release. In this work, fast-scan cyclic voltammetry at carbon-fiber microelectrodes was used to quantify striatal reserve pool dopamine in knockout mice and wild-type control mice. Reserve pool dopamine efflux, induced by amphetamine, was measured in brain slices from knockout and wild type mice in the presence of α-methyl-p-tyrosine, a dopamine synthesis inhibitor. Additionally, the stimulated release of reserve pool dopamine, mobilized by cocaine, was measured. Both efflux and stimulated release measurements were enhanced in slices from knockout mice, suggesting that these mice have greater reserve pool dopamine stores than wild-type and that these stores are effectively mobilized. Moreover, dopamine transporter labeling data indicate that the difference in measured dopamine efflux was likely not caused by altered dopamine transporter protein expression. Additionally, slices from MsrA −/− and wild-type mice were equally responsive to increasing extracellular calcium concentrations, suggesting that potential differences in either calcium entry or intracellular calcium handling are not responsible for increased reserve pool dopamine release.
now just being revealed. Many of these conditions, such as Parkinson's disease, Huntington's disease, and Lou Gehrig's disease, have been associated with the increased production or reactive oxygen species, thereby enhancing the degree of cell oxidative stress in the brain (Patten et al., 2010 , Cohen, 1983 , Perez-Severiano et al., 2004 .
Interestingly, elevated DA levels have also been associated with enhanced oxidative stress (Oien et al., 2008b) . Indeed, one model of oxidative stress, methionine sulfoxide reductase A knockout (MsrA −/− ) mice, have been reported to have chronically high brain DA levels (Oien et al., 2008b) . These mice lack the antioxidant enzyme MsrA, which is part of the Msr system. Methionine sulfoxide posttranslational modifications can be reversed by the Msr system, which consists of MsrA (reduces S methionine sulfoxide enantiomer) and MsrB (reduces R methionine sulfoxide enantiomer) (Moskovitz, 2005) . The MsrA −/− mouse is hypersensitive to oxidative stress, accumulates higher levels of carbonylated protein, and expresses brain pathologies associated with neurodegenerative diseases (Moskovitz et al., 2001 , Pal et al., 2007 . Recent studies have shown that these mice have abnormally high DA levels in the brain at the ages of 6 and 12 months, compared to wild type (WT) control mice. Additionally, these high levels parallel an increased presynaptic DA release when stimulated in vitro without drug treatments.
A possible mechanism for an increase in stimulated DA release in MsrA −\− mice involves the mobilization of reserve pool DA. In general, DA-containing vesicles are believed to be separated into three pools: the readily releasable pool (RRP), the recycling pool, and the reserve pool (Neves and Lagnado, 1999, Rizzoli and Betz, 2005) . The RRP undergoes exocytosis upon mild stimulation and is replenished by the mobilization of the recycling pool vesicles. The reserve pool, mobilized upon prolonged periods of synaptic activity (Neves and Lagnado, 1999) , is the largest pool consisting of 80-90% of the total vesicles (Rizzoli and Betz, 2005) . Pharmacological manipulations, using a combination of alphamethyl-p-tyrosine (aMPT) and either cocaine (COC) or amphetamine (AMPH) (Venton et al., 2006 , have been used to quantitatively measure reserve pool dopamine.
Other factors, such as calcium transport, may also influence the amplitude of stimulated dopamine release plots. Transient increases in intracellular calcium concentration trigger vesicular exocytosis (Nachshen and Sanchez-Armass, 1987, Kume-Kick and Rice, 1998) as well as the movement of RRP and reserve pool vesicles (Rose et al., 2002) . Moreover, the increase in oxidative stress may result in calcium dysregulation. For example, the activity of calmodulin, a calcium regulatory protein that activates the plasma membrane calcium ATPase (PMCA), diminishes due to oxidative post-translational modifications as tissues age (Michaelis et al., 1996) . The oxidation of specific methionines in calmodulin results in about a 50% reduction of PMCA activation (Bartlett et al., 2003) , thereby impairing the ability of cells to clear calcium from the cell (Palacios et al., 2004) . Oxidized calmodulin can accumulate in brain tissues as a result of low antioxidant levels and it is speculated that oxidation of methionines on calmodulin may be acting as a molecular switch in calcium regulation, oxidative stress, and DA release (Chen et al., 2001, Bigelow and Squier, 2005) .
To investigate possible mechanisms underlying elevated DA content and release found in MsrA −/− mice, fast-scan cyclic voltammetry (FSCV) at carbon-fiber microelectrodes was used to measure the mobilization and efflux of reserve pool DA in striatal brain slices from MsrA −/− mice and WT control mice (Oien et al., 2008b) . We hypothesized that the DA reserve pool is enhanced in MsrA −/− mice compared to WT control mice. In order to measure reserve pool DA, slices were pre-treated with αMPT and then treated with either AMPH, to measure the efflux of reserve pool DA, or with COC, to measure the stimulated release of mobilized DA reserve pool vesicles. Collectively, our results suggest that reserve pool DA is more abundant in the MsrA −/− striatum and that the number of vesicles is greater compared to WT controls.
Experimental Procedures Animals
The MsrA −/− and WT control mice have been described previously (Moskovitz et al., 2001 ). All mice used in these experiments were fed ad libitum, housed with 12 h of light per day, and caged individually. All procedures and conditions of live mice, including euthanasia, were approved by the University of Kansas Institutional Animal Care and Use Committee. Every effort was made to minimize the number of animals used and animal suffering.
Brain Slice Preparation
Brain slices of 12-month-old MsrA −/− mice and age-matched WT control mice were prepared as previously described (Johnson et al., 2006) . Brain slices were used as an experimental preparation because they allow for the direct measurement of locally evoked DA release and generally provide higher throughput than whole animal preparations. Mice were anesthetized by isoflurane inhalation and then decapitated. The brain was immediately removed and placed in ice cold artificial cerebrospinal fluid (aCSF) consisting of (mM): NaCl 126, KCl 2.5, NaH 2 PO 4 1.2, CaCl 2 2.4, MgCl 2 1.2, NaHCO 3 25, HEPES 20, and DGlucose 11. The pH of the aCSF was adjusted to 7.4. The cerebellum was removed from the brain using a razor blade and the brain was then mounted on an aluminum block. A vibratome slicer (Leica, Wetzlar, Germany) was used to make 300 µm thick coronal slices. Each brain slice was equilibrated in the superfusion chamber which was maintained at 34°C, through which aCSF flowed at a continuous rate of 2 mL/min, prior to obtaining measurements.
DA Release in Brain Slices
Carbon-fiber microelectrodes were fabricated using a single 7 µm diameter carbon-fiber (Goodfellow Cambridge Ltd, Huntingdon, U.K.) that was aspirated through a glass capillary tube (1.2 mm outer diameter, 0.68 mm inner diameter, 20 mm long, A-M Systems, Inc. Carlsborg, WA), and was pulled using a heated coil puller (Narishige International USA, Inc., East Meadow, NY) (Kraft et al., 2009 ). The carbon-fiber was trimmed to about 25 µM and further insulated using with epoxy resin (EPON resin 815C, EPIKURE 3234 curing agent, Miller-Stephenson, Danbury, CT, USA), and then cured at 100°C for 1 h. The electrodes were backfilled with 0.5 M potassium acetate to provide an electrical connection between the carbon fiber and an inserted silver wire.
A triangular waveform was applied to the carbon-fiber electrode starting at −0.4 V, increasing to +1.0 V, and then scanning back down to −0.4 V. For stimulated release measurements, a scan rate of 300 V/s and an update rate of 60 cyclic voltammograms (CVs) per second were used. For measurements of AMPH-induced DA efflux, an update rate of 5 CVs was used to limit the memory space occupied by the file. A headstage amplifier (UNC Chemistry Department Electronics Design Facility, Chapel Hill, NC) was interfaced with a computer via a breakout box and custom software provided by R.M. Wightman and M.L.A.V. Heien (University of North Carolina, Chapel Hill). A Ag/AgCl reference electrode consisted of a chorided silver wire. The carbon fiber microelectrode was inserted 100 µm into the dorsolateral caudate-putamen region of the striatum between the prongs of a bipolar stimulation electrode (Plastics One, Roanoke, VA), which was separated by a distance of 200 µm. A single pulse at 60 Hz was applied to the brain slice and the current was then measured at the peak oxidation potential for DA (about +0.6 V versus Ag/AgCl reference electrode). Working electrodes were calibrated with DA standards of known concentration in a flow cell before and after each use. The average of pre-and postcalibration measurements was used as the calibration factor. Drugs were introduced into the brain slice superfusion chamber by opening a three-way valve that allowed the desired solution to flow by gravity feed.
For AMPH-induced DA efflux experiments, brain slices were stimulated with single electrical stimulus pulses until the magnitude of evoked DA release was consistent between measurements. Brain slices were then treated with 50 µM aMPT. During this treatment, stimulated DA release was measured every 5 min. Once DA release diminished, 20 µM AMPH was added to the aCSF/aMPT solution and a 25 min duration file was collected.
To measure electrically evoked DA release from mobilized reserve pool vesicles, the same procedure for pre-treatment with aMPT was used. However, slices were treated with 20 µM COC after stimulated release was diminished. During this treatment, electrically-evoked release was measured every 5 minutes.
Sensitivity of DA release to extracellular calcium
To measure changes in the sensitivity to calcium in MsrA −/− mice DA release evoked by a single electrical stimulus pulse was first measured in slices with aCSF that contained 2.4 mM calcium. Next, aCSF containing 0 mM calcium was introduced into the superfusion chamber. Once DA release disappeared, brain slices were cumulatively treated with aCSF containing 0.6, 1.2, 1.8, and 2.4 mM calcium. Slices were treated with each concentration for 15 min, with files collected every five 5 min using a single pulse stimulation. Values obtained at the 15 min point were used in Fig. 4 .
Immunoblotting
MsrA −/− and WT brains were dissected from post-mortem mice. Each striatal lysate was placed in a glass tube and homogenized with Teflon in 50 mM HEPES buffer pH 7.4 plus protease inhibitors (Roche) at 4°C. Homogenized extract was centrifuged for 20 min to separate the membrane fraction. Buffer containing 50 mM HEPES, 0.62% CHAPS, and 150 mM NaCl was added to each membrane fraction and agitated for 30 min. Each fraction was centrifuged for 20 min. Protein concentration of the supernatant was determined by BCA Protein Assay Kit (Pierce). Equal protein amounts (20 µg) of each soluble membrane fraction was loaded into a HEPES 4-20% Protein Gel (Pierce, Pittsburg, PA) for electrophoretic separation. Proteins were transferred to a nitrocellulose membrane and blocked overnight in 5% dry milk in buffer. DAT band was detected using primary rabbit anti-DAT antibodies (1:1000; Chemicon, Billerica, MA). Peroxide-conjugated goat-antirabbit antibodies were used as secondary antibodies (1:2000; Bio-Rad, Hercules, CA). Protein bands were visualized by chemiluminescent substrate and exposure to autoradiography film. Densitometry analysis was done using ImageJ software (publicly available software obtained from the National Institutes of Health website).
Statistical Analyses
Data were analyzed by ANOVA or students t-test using GraphPad Prism 4.03 (GraphPad Software, Inc., La Jolla, CA). All numerical values are represented as mean ± SEM. A p value of 0.05 or less was considered significant.
Results

Reserve Pool DA Levels
It has been previously demonstrated that in MsrA −/− mice stimulated DA release, evoked by a single-pulse electrical stimulation, is significantly higher than that of WT controls (Oien et al., 2008b) . To determine if reserve pool DA is similarly more abundant in MsrA −/− mice, striatal brain slices were subjected to treatment with aMPT and AMPH-induced efflux was measured. Each slice was treated with 50 µM aMPT to inhibit tyrosine hydroxylase, the rate limiting enzyme in DA synthesis. A stimulus pulse was then applied to the slice every 5 min until DA release was diminished. At this point, DA remaining in terminals consisted only of reserve pool DA. The slices were then treated with 20 µM AMPH, a competitive DAT inhibitor that induces the quantitative efflux of cytosolic and vesicular DA. AMPH enters the pre-synaptic terminals in one of two ways: either by lipophilic diffusion through membranes or by passage through DAT protein molecules (Fischer and Cho, 1979, Liang and Rutledge, 1982) . AMPH displaces vesicular DA into the cytoplasm and induces DA reverse transport, caused by allosteric translocation of the DAT protein molecules (Chiueh and Moore, 1975, Jones et al., 1998) . The AMPH induced efflux of DA was measured over the course of 25 min and the amplitude of the DA peak ([DA] AMPH ) was used to determine the amount of DA released (Fig.1a) . A CV, which has an oxidation peak at ~0.6 V and a reduction peak at ~−0.2 V, shown at the peak current on this efflux curve indicates that the species released by AMPH treatment is DA. In MsrA −/− mice, AMPH-induced DA efflux was significantly greater than that observed in WT control mice, indicating that the striatal DA reserve pool is enhanced in MsrA −/− mice ( Fig. 1b ; p = 0.022; MsrA −/− , 7.02 ± 1.42 µM, n = 5 mice; WT, 5.63 ± 0.33 µM, n = 4 mice).
Mobilization of Reserve Pool DA
To identify differences in the exocytotic release of mobilized DA reserve pool vesicles, DA release, electrically evoked in striatal brain slices from MsrA −/− and WT mice control mice, was measured with FSCV ( Fig. 2a) . Once DA release peak amplitude was the same between separate stimulations in the absence of drug, aMPT was added to the perfusate at a final concentration of 50 µM in order to stop DA synthesis. After DA release was diminished, COC was added to the aMPT/aCSF solution at a final concentration of 20 µM. COC has previously been shown to mobilize reserve pool DA (Venton et al., 2006) . DA release was electrically evoked by the application of locally applied single stimulus pulses every 5 min throughout the entire process. The addition of COC caused stimulated DA release to grow in both MsrA −\− and WT control slices. Although COC treatment caused DA release to increase to similar levels in MsrA −/− and WT control slices, DA release reappeared for a longer amount of time in slices from MsrA −/− mice (~180 min) compared to slices from WT mice (~80 min) (Fig. 2b) . The area under the curve generated using slices from WT mice was 40% of that generated using slices from MsrA −/− mice.
DAT Protein Levels
The DAT is a transmembrane protein that moves DA from the synaptic cleft into the presynaptic neuron. In membrane fractions of MsrA −/− and WT mice, no difference in DAT protein levels was detected ( Fig. 3 ; p = 0.65; MsrA −/− , 115.6 ± 4.1 %, n = 3 mice; WT, 100.0 ± 19.8 %, n = 3 mice). These data are consistent with a previous report that showed synaptic DA clearance was similar between MsrA −/− and WT mice (Oien et al., 2008) .
Extracellular Calcium Sensitivity
Vesicular DA exocytosis in the striatum is directly dependent on available extracellular calcium, which enters pre-synaptic terminals by voltage-gated calcium channels during membrane depolarization (Heuser and Reese, 1973; Cremona and De Camilli, 1997) . In order to evaluate whether the calcium dependency of release was altered in MsrA −/− mice, brain slices were treated with various concentrations of extracellular calcium and stimulated DA release was measured (Fig. 4) . All peak DA release values were normalized against peak DA release obtained at 2.4 mM Ca 2+ , which is the concentration of Ca 2+ present in the aCSF that was used for measuring the total amount of DA present in the reserve pool (Figs 1 and 2 ). The purpose of this normalization was to minimize variation caused by heterogeneity in dopaminergic innervation found in the striatum. A two-way ANOVA did not reveal an overall genotype effect on DA release throughout the entire range of extracellular calcium concentrations ( Fig. 4 ; p = 0.97; F 1,44 = 0.00; MsrA −/− , n = 4 to 6 mice; WT, n = 6 mice).
Discussion
Previous studies using MsrA −/− mice have shown that DA release evoked using a singlepulse stimulation is increased (Oien et al., 2008b) . In the present study, differences in DA reserve pool storage and mobilization in striatal brain slices from MsrA −/− mice and WT control mice were examined. AMPH-induced DA efflux, following pre-treatment with αMPT, was increased in striatal brain slices from MsrA −/− mice compared to those of WT littermates. Moreover, MsrA −/− slices showed an enhanced degree of COC-induced mobilization of DA reserve pool vesicles compared to WT. Furthermore, slices from MsrA −/− mice and WT control mice were equally sensitive to changes in extracellular calcium concentration.
Initial experiments were aimed at determining if alterations in either DAT or calcium regulation preferentially enhanced DA release in MsrA −/− mice. Our previous work has shown that the efficiency of DA reuptake by DAT is similar in MsrA −/− and WT mice (Oien et al., 2008b) . Furthermore, here we show that DAT protein levels are similar in MsrA −/− and WT mice. This result further supports the concept that DAT function and protein levels are not altered in the absence of MsrA. Therefore, we expect that COC and AMPH effects on the DAT would be similar in both mice genotypes.
The exocytotic release of DA during synaptic transmission is mediated by calciumdependent fusion with the active zone (Heuser and Reese, 1973; Cremona and De Camilli, 1997; Kavalali, 2006) . Thus, the ability of extracellular calcium to enter through N-and P/ Q-type voltage-gated calcium channels (VGCCs) located at the active zone exerts a strong influence over neurotransmitter release (Fox and Currie, 1997) . We observed no difference in electrically evoked DA release between MsrA −/− and WT slices when extracellular calcium concentrations were increased, suggesting that the VGCCs were functioning similarly. However, it is important to note that this experiment, due to its limited scope, cannot rule out potential alterations in other calcium handing mechanisms in MsrA −/− mice, and the possibility that such alterations may somehow influence the ability of terminals to release DA, especially since intracellular calcium can influence the movement of vesicular DA between RRP and reserve pools (Rose et al., 2002) .
One potential mechanism that could increase intracellular calcium levels, although not supported by the data presented in this report, is the oxidative inactivation of calcium regulatory proteins. In particular, methionine oxidation of calcium regulatory proteins, such as calmodulin (Michaelis et al., 1996) and calcium/calmodulin kinase II (Erickson et al., 2008) , increases with age and is also increased in selenium deficient MsrA −/− mice compared to WT control mice (Moskovitz, 2007) . Data obtained using patch clamp methods in several cell types (Zucker and Regehr, 2002) , including studies conducted using dopaminergic retinal amacrine cells (Borges et al., 1995) and retinal bipolar cells (Gomis et al., 1999) , suggest that the translocation of reserve pool vesicles are influenced by changes in intracellular Ca 2+ levels. Thus, it seems plausible that fluctuations in intracellular Ca 2+ levels associated with a lack of calcium chelating ability would influence reserve pool DA mobilization in MsrA −/− mice.
To assess the content and mobilization of reserve pool DA in MsrA −/− and WT control mice, selected pharmacological agents were used. Treating brain slices with aMPT while electrically stimulating the brain slice depletes DA in RRP vesicles. Under these conditions, DA in the extracellular space will be packaged and also released, leaving only DA in reserve pool vesicles . Upon the addition of AMPH, DA in the reverse pool vesicles is released by reverse transport through the DAT and we are able to measure the resulting efflux. We found that, compared with WT littermate controls, AMPH-induced DA efflux is greater in MsrA −/− slices compared to WT slices, indicating that MsrA −/− mice have an increased supply of reserve pool dopamine. This increase parallels both the enhancement of stimulated DA release and the increase in striatal DA content found previously in MsrA −/− mice (Oien et al., 2008b) . Because it appears that similar equal levels of the DAT protein are found in MsrA −/− and WT mice, and DA uptake in the absence of pharmacological treatments appears to be similar between the two strains, it is unlikely that the enhancement of DA efflux found in the MsrA −/− striatum is the result of alterations in DAT expression or function. Thus, our results suggest that the overall amount of reserve pool DA is increased in the MrsA −/− striatum.
When DA reserve pool vesicles are mobilized by the application of COC, peak DA release evoked by single-pulse stimulation was the same between the MsrA −/− and WT mice, implying that there are the same number of DA molecules contained in each mobilized reserve pool vesicle. Because the peak dopamine release is attained earlier in WT mice than in MsrA −/− mice, impaired mobilization of reserve pool vesicles in the MsrA −/− cannot be ruled out. The area under the curve generated from WT slices was about 40% of the area under the curve generated from MsrA −/− slices. Because the peak amounts of DA released by WT and MsrA −/− slices following cocaine treatment were unchanged, we speculate that the genotypes have similar amounts of DA packaged in the vesicles. If this is indeed the case, then the area under the curve calculations would suggest that the WT striatum possesses 40% the number of DA reserve pool vesicles found in the MsrA −/− striatum. This figure is in close agreement with the amount of DA released by electrical stimulation in the WT striatum (37% of MsrA −/− ; Oien et al., 2008b) . Thus, it may be that a greater overall number of vesicles, albeit a similar proportion in relation to the reserve pool, are mobilized into the RRP in MsrA −/− mice than in WT mice. These vesicles then undergo exocytosis upon the application of a mild electrical stimulus pulse, which is intended to simulate the occurrence of a natural action potential. We speculate that this increase in the number of reserve pool vesicles enhances the magnitude of naturally occurring DA release events in MsrA −/− mice.
The mechanism of the chronically increased DA levels in MsrA −/− mice is still unknown. The abnormally high brain DA in MsrA −/− mice can be alleviated by caloric restriction , suggesting that metabolism and oxidative stress related mechanisms are involved in this phenomenon. Previous studies suggest an increase of the tyrosine hydroxylase activating protein 14-3-3zeta mRNA (Oien et al., 2008a) and protein (Oien et al., 2008b ) may be associated with the increased levels of DA by enhanced DA synthesis. In addition, we have recently reported that methionine oxidation of the dopamine D2 receptor may participate in DA signaling in MsrA −/− mice , which may include the presynaptic D2 autoreceptor isoform. Another possible explanation for this abnormal DA regulation is increased methionine sulfoxide levels in alpha-synuclein that may interfere with its interaction with DA (Oien and Moskovitz, 2008 , Oien et al., 2009 , Outeiro et al., 2009 ). This theory is further supported by defective mobilization of DA from reserve pools in alpha-synuclein knockout mice and A30P mutated alpha-synuclein transgenic mice (Yavich et al., 2004 , Yavich et al., 2005 . In any case, it is apparent that dopaminergic neurons store this excess DA in reserve pool vesicles.
In summary, this work indicates that MsrA −/− mice have an increase amount of DA stored in the striatal reserve pool compared to WT control mice. To our knowledge, this is the first published study in which reserve pool DA levels have been directly measured in mice that are genetically altered to have increased oxidative stress. Moreover, this study offers a potential mechanism by which neurons cope with the excessive production of DA, and also provides a strategy for the study other DA-related pathologies. Brain slices were treated with 0, 0.6, 1.8, and 2.4 mM concentrations of extracellular calcium and electrically stimulated DA release was measured for 15 min at each concentration. DA release was normalized to maximum DA release within each data set. At 0 mM calcium no DA release was detected. Two-way ANOVA did not reveal an overall genotype effect on DA release throughout the entire range of extracellular calcium concentrations ( Fig. 4 ; p = 0.51; F 1,21 = 0.48; MsrA −/− , n = 4 mice; WT, n = 6 mice).
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